[Serum immunoglobulins in parenteral drug addicts]. 1987

E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006942 Hypergammaglobulinemia An excess of GAMMA-GLOBULINS in the serum due to chronic infections or PARAPROTEINEMIAS. Hyperimmunoglobulinemia,Hypergammaglobulinemias,Hyperimmunoglobulinemias
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú
January 1979, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú
January 1989, Enfermedades infecciosas y microbiologia clinica,
E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú
January 1986, Scandinavian journal of infectious diseases,
E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú
January 1986, Medicina clinica,
E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú
August 2004, Vnitrni lekarstvi,
E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú
July 1986, Medicina clinica,
E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú
December 1995, Revista clinica espanola,
E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú
January 1995, Revista clinica espanola,
E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú
February 1994, Revista clinica espanola,
E Aguilar Ligorit, and J Guix García, and A Sánchez Mañez, and A Pascual López, and B San Martín Echauri, and A Lluch Hernández, and V Alberola Candel, and J García-Conde Brú
March 1999, Revista clinica espanola,
Copied contents to your clipboard!